Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma
出版年份 2016 全文链接
标题
Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma
作者
关键词
Cytotoxic T lymphocyte, Immune response, Immunotherapy, Oesophageal adenocarcinoma, Regulatory T cells, Tumour regression
出版物
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 65, Issue 6, Pages 651-662
出版商
Springer Nature
发表日期
2016-03-28
DOI
10.1007/s00262-016-1826-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
- (2014) S. Loi et al. ANNALS OF ONCOLOGY
- The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis
- (2014) Ezzeldin M. Ibrahim et al. BREAST CANCER RESEARCH AND TREATMENT
- Strategies to improve outcomes in esophageal adenocarcinoma
- (2014) Andrew Cowie et al. Expert Review of Anticancer Therapy
- Critical role of spatial interaction between CD8+ and Foxp3+ cells in human gastric cancer: the distance matters
- (2013) Anita Feichtenbeiner et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
- (2013) L Bracci et al. CELL DEATH AND DIFFERENTIATION
- Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers
- (2013) Kyung-Ju Kim et al. HUMAN PATHOLOGY
- Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients – an immunohistochemical study of cd8+ and foxp3+ using double immunostaining with correlation to the pathobiological response of the patients
- (2013) Monica SM Chan et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
- The role of systemic inflammatory and nutritional blood-borne markers in predicting response to neoadjuvant chemotherapy and survival in oesophagogastric cancer
- (2013) Fergus Noble et al. MEDICAL ONCOLOGY
- Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus
- (2013) Fergus Noble WORLD JOURNAL OF GASTROENTEROLOGY
- The Relationship Between Tumor Inflammatory Cell Infiltrate and Outcome in Patients with Pancreatic Ductal Adenocarcinoma
- (2012) Nigel B. Jamieson et al. ANNALS OF SURGICAL ONCOLOGY
- Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer
- (2012) Hui Liu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer
- (2012) Foluso O. Ademuyiwa et al. PLoS One
- Interrelationships between Tumor Proliferative Activity, Leucocyte and Macrophage Infiltration, Systemic Inflammatory Response, and Survival in Patients Selected for Potentially Curative Resection for Gastroesophageal Cancer
- (2011) Andrew B. C. Crumley et al. ANNALS OF SURGICAL ONCOLOGY
- The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
- (2011) M J M Gooden et al. BRITISH JOURNAL OF CANCER
- Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy
- (2011) N. Halama et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study
- (2011) Michael J. Proctor et al. EUROPEAN JOURNAL OF CANCER
- Guidelines for the management of oesophageal and gastric cancer
- (2011) W. H. Allum et al. GUT
- Comparison of the Prognostic Value of Tumour- and Patient-Related Factors in Patients Undergoing Potentially Curative Resection of Oesophageal Cancer
- (2011) Sumanta Dutta et al. WORLD JOURNAL OF SURGERY
- Fc R2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancer
- (2010) K. Tamura et al. ANNALS OF ONCOLOGY
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus
- (2010) U. Zingg et al. EJSO
- Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer
- (2010) J. A. D. Simpson et al. GUT
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Tumour regression grade (TRG) analyses in patients with resectable gastro-oesophageal adenocarcinomas treated with platinum-based neoadjuvant chemotherapy
- (2009) Khaleel R Fareed et al. HISTOPATHOLOGY
- Continuing Rapid Increase in Esophageal Adenocarcinoma in England and Wales
- (2008) Côme Lepage et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Cancer treatment: the combination of vaccination with other therapies
- (2008) Mads Hald Andersen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells
- (2008) S. Ladoire et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now